Follow
A Ferrer Artola
A Ferrer Artola
Hospital Universitari de Bellvitge-Idibell
Verified email at bellvitgehospital.cat
Title
Cited by
Cited by
Year
Response to idebenone and multivitamin therapy in Leber’s hereditary optic neuropathy
ALAIAA RESPUESTA, ENNÓ MULTIVITAMINOTERAPIA
Arch Soc Esp Oftalmol 82, 377-380, 2007
672007
Outcomes of off-label drug uses in hospitals: a multicentric prospective study
I Danés, A Agustí, A Vallano, C Alerany, J Martínez, JA Bosch, A Ferrer, ...
European journal of clinical pharmacology 70, 1385-1393, 2014
392014
Available evidence and outcome of off-label use of rituximab in clinical practice
I Danés, A Agustí, A Vallano, J Martínez, C Alerany, A Ferrer, A López, ...
European journal of clinical pharmacology 69, 1689-1699, 2013
292013
Off-label drug use in hospitals
I Danés, C Alerany, A Ferrer, A Vallano
Medicina Clínica 143 (7), 327-328, 2013
22013
L'homeopatia, ciència o creeça?
M Suils, B Oliveras, L Palou, F Farjas, A Ferrer, R Nassarre, L Ramón
Perspectiva escolar, 30-34, 2019
2019
Off-label drug use in hospitals
I Danés, C Alerany, A Ferrer, A Vallano
Medicina clinica 143 (7), 327-328, 2014
2014
Off-label Use in Five Tertiary Hospitals: Available Evidence and Outcome
I Danes, A Agusti, C Valdivia, M Duero, E Ballarin, E Perez, A Vallano, ...
Basic & Clinical Pharmacology & Toxicology 113 (Supplement 2), 9-9, 2013
2013
Capsulorexis con azul de metileno
T Casasín i Edo, A Salvador Payá, M Fossas Real, JC Raitieri Florença, ...
Atención farmacéutica 15 (8), 504-505, 1998
1998
Capsulorrhexis with methylene blue
T Casasin i Edo, A Salvador Playa, M Fossas Real, JC Raitieri Florenca, ...
FARMACIA CLINICA 15, 504-505, 1998
1998
Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy
The system can't perform the operation now. Try again later.
Articles 1–10